Panagora Asset Management’s Xenetic Biosciences XBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding XBIO
SM
VF
RE
Panagora Asset Management's XBIO Position: Q3 2019 in Review
Panagora Asset Management sold out of Xenetic Biosciences (XBIO) in Q3 2019, closing a stake of 34 shares — an estimated $4K sold.
Panagora Asset Management first reported a position in XBIO in Q3 2017 and held it in 8 quarters. The position peaked at $32K in Q1 2019. 8 funds tracked by Wall St. Rank hold XBIO as of Q3 2019.
- Panagora Asset Management reported no remaining Xenetic Biosciences position as of Q3 2019 after selling out during the quarter.
- Panagora Asset Management sold 34 Xenetic Biosciences shares in Q3 2019, an estimated $4K.
- Panagora Asset Management first reported a position in Xenetic Biosciences in Q3 2017 and held it in 8 quarters.
- Panagora Asset Management's Xenetic Biosciences position peaked at $32K in Q1 2019.
- 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2019.
Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.